Nano-X Imaging (NNOX) Cash & Equivalents (2020 - 2024)
Nano-X Imaging's Cash & Equivalents history spans 5 years, with the latest figure at $39.3 million for Q4 2024.
- For Q4 2024, Cash & Equivalents fell 30.28% year-over-year to $39.3 million; the TTM value through Dec 2024 reached $39.3 million, down 30.28%, while the annual FY2024 figure was $39.3 million, 30.28% down from the prior year.
- Cash & Equivalents reached $39.3 million in Q4 2024 per NNOX's latest filing, down from $56.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $213.8 million in Q4 2020 to a low of $38.5 million in Q4 2022.
- Average Cash & Equivalents over 5 years is $82.9 million, with a median of $56.4 million recorded in 2023.
- Peak YoY movement for Cash & Equivalents: crashed 68.83% in 2021, then soared 46.57% in 2023.
- A 5-year view of Cash & Equivalents shows it stood at $213.8 million in 2020, then plummeted by 68.83% to $66.6 million in 2021, then tumbled by 42.29% to $38.5 million in 2022, then skyrocketed by 46.57% to $56.4 million in 2023, then tumbled by 30.28% to $39.3 million in 2024.
- Per Business Quant, the three most recent readings for NNOX's Cash & Equivalents are $39.3 million (Q4 2024), $56.4 million (Q4 2023), and $38.5 million (Q4 2022).